Recent News

Envoy Medical Reports Third Quarter 2026 Results and Highlights Continued Progress

Nov 5, 2026, 9:24:48 AM

Company Reaches Six-Month Milestone in Pivotal Trial of Fully Implanted Cochlear Implant

Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design

Oct 20, 2026, 5:58:10 PM

Company Believes It Is the First to Reach This Milestone in a U.S. Pivotal Trial of a Fully Implante...

Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

Oct 12, 2026, 8:45:38 AM

Second of Four Planned Modules Moves Rolling FDA Review Forward

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

Sep 22, 2026, 9:04:39 AM

Canadian and Hong Kong Patents Continue to Strengthen Intellectual Property Protection Across Envoy ...

Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

Sep 2, 2026, 8:59:10 AM

White Bear Lake, Minnesota--(Newsfile Corp. - September 2, 2026) -Envoy Medical®Inc. (NASDAQ: COCH) ...

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Aug 10, 2026, 10:47:51 AM

Submitted First Module of Modular PMA Application to FDA

Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial

Jul 21, 2026, 8:33:50 AM

White Bear Lake, Minnesota--(Newsfile Corp. - July 21, 2026) -Envoy Medical® Inc.(NASDAQ: COCH) ("En...

Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant

Jul 14, 2026, 8:36:08 AM

Mean CNC word recognition scores for Stage 1 cohort improved to 53.2% at 12 months from 15.2% pre-im...

Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device

Jun 30, 2026, 8:36:30 AM

Modular Regulatory Strategy Creates Defined Milestone Cadence, Enables Earlier FDA Engagement, and S...

Envoy Medical Terminates At-the-Market (ATM) Equity Facility

Jun 25, 2026, 9:01:38 AM

Termination Reflects Company's Confidence in Current Capital Position

*The materials and resources presented are intended to be an educational resource for general purposes only. They are not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician. Each person’s situation is unique and risks, outcomes, experience and results may vary. CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by federal (or United States) law to investigational use.

**See Important Information here.

News Room